\[ \large\mathcal{YiHsin}\;\mathcal{Sam}\;\mathcal{Lu} \]

【Summary】 Patients increasing:

  • Increasing “all levels” (e.g. Gender)
  • Increasing “one level” (e.g. Cell type)
  • “Yes>No” to “No>Yes” (e.g. Mortality)
  • Total: 4682

N

1 Variables

ECOG

  • 0 無症狀
  • 1 有症狀,可步行對生活不影響
  • 2 躺在床上時間小於50%
  • 3 躺在床上時間大於50%
  • 4 完全臥床

Gender

Age

BMI

  • 1 Normal: \(\leq25\)
  • Overweight: \(>25\)

Cell Type

  • 1 Urothelial
  • 2 Squamous
  • 3 Small cell
  • 4 Adenocarcinoma
  • 5 UC with variants (Squamous cell, glandular, sarcomatous, micro papillary, neuroendocrine, lymphoepithelial)
  • 6 Others

Side

Location

  • 0 Non-visible
  • 1 Renal pelvis
  • 2 Ureter (“2 上輸尿管”、“3 中輸尿管”、“4 下輸尿管”、“6 Urerter, unknown site”)
  • 3 Bladder cuff (“5 膀胱袖口”)
  • 4 Multiple locations (多選)

Multiple

Size

Biopsy Method

pT Stage

Bladder Cancer

CIS

LVI

Surgical Margin

Pre-operative Hydronephrosis

Tumor Necrosis

Chemotherapy (UTUC)

Chemotherapy Type (UTUC)

Chemotherapy Prescription (UTUC)

Radiation Therapy

Radiation Therapy Type

Surgery Method

NxUx Method

NxUx Access

Endoscopic Method

Segmental Method

Segmental Access

Bladder Cuff Resection

Simultaneously Ipsilateral Adrenalectomy

Post_operation Intravesical C/T Instillation

2 Outcomes

Clavien Dindo Classification

Mortality

Disease Free

Cancer Specific

Bladder Free